Vertex Pharmaceuticals Incorporated Selects NEXUS Biosystems' Universal Store for Global Compound Management

    POWAY, CALIF., March 28 /CNW/ - NEXUS Biosystems announced that Vertex
Pharmaceuticals Incorporated recently selected the Universal Store system to
serve as the main repository for maintaining and managing their global
compound collection.

    The Universal Store system will become a central component of the
discovery operations function at Vertex's San Diego research site, enabling
Vertex to support global screening demand across all its research sites. The
discovery operations team utilizes state-of-the-art instrumentation and data
management tools to enable high throughput data generation within the Vertex
research community.

    "Vertex required a compound storage and management system that had a high
degree of flexibility, functionality, and scalability. The Universal Store
family of products was designed to meet demanding drug discovery automation
requirements such as these through its unique combination of performance,
modularity, and reliability," said Tommy Bui, VP of Business Development at
NEXUS Biosystems. "We are extremely pleased to be working collaboratively with
Vertex to not only integrate the Universal Store into its discovery operations
but also improve our technology through a close dialogue and partnership."

    "We are excited to work closely with NEXUS to deploy its compound storage
and management system as a part of our compound management platform," said
Hans Recker, Sr. Director of Discovery Operations at Vertex. "In today's
continuously changing discovery environment, technology platforms need to
offer both robust efficiency and adaptability to remain competitive throughout
their life cycles. We conducted an extensive evaluation of the compound
management systems currently available and found the NEXUS Universal Store to
be well suited to address our long term strategic needs."

    About NEXUS Biosystems, Inc.

    NEXUS Biosystems, a privately held company based in Poway, California,
USA, has since 1996 been a developer and provider of enabling technologies and
automation systems for pharmaceutical, biotech, agrochemical and academic
research institutions worldwide. Current products include the Universal
Store(R) family of next generation sample storage and retrieval systems, the
Crystal Farm(R) line of protein crystallization systems, the IRORI(R) line of
chemical synthesis technologies and services, and in No. America and Asia
NEXUS is a distributor of the Covaris(TM) line of ultrasonic products for
sample dissolution, resolubulization, and high density microplate mixing.

    About Vertex Pharmaceuticals Incorporated

    Vertex Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small molecule
drugs for serious diseases. The Company's strategy is to commercialize its
products both independently and in collaboration with major pharmaceutical
companies. Vertex's product pipeline is focused on viral diseases,
inflammation, autoimmune diseases, cancer, pain and bacterial infection.
Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.

For further information:

For further information: NEXUS Biosystems Tommy Bui, VP, Business
Development, 858-679-0770

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890